Clinical trial data and post-marketing surveillance have documented gastrointestinal complaints in a substantial proportion of patients, with nausea being the most frequent (reported in 1540% of patients depending on the specific agent and dose), followed by vomiting, diarrhoea, constipation, and dyspepsia
Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) and a nested case-control study (Bezin et al., 2023) that reported increased risk for thyroid cancer following GLP-1 RA-based interventions
I teach parents basic concepts around how to expose their children to anxiety-producing situations to decrease their anxiety. She helps children learn coping strategies, like deep breathing and muscle relaxation
Is the primary care system addressing the hard health issues in cardiac care
Healthcare professionals emphasize that these patches cannot replicate the proven benefits of GLP-1 injections, which include not only weight loss but also improvements in cardiovascular health and blood sugar control
Tamura K, Yamaji T, Yamada T, Ohsawa M, Wakui H
